Mechanistically, UBE2O should contribute to reduced amyloid-β (Aβ) deposit, but the accumulation of the Aβ protein precursor (AβPP) with a pathogenic mutation for AD reduces the expression of UBE2O. Here, UBE2O is linked to Alzheimer disease.